|
Minimally invasive image-guided tumor ablation in an oncogenic pig model
|
5R21CA195433-02
|
$266,380
|
BURDETTE, EVERETTE
|
ACOUSTIC MEDSYSTEMS, INC.
|
|
Establishment of a patient-like mouse models of soft-tissue sarcoma sub-types
|
1R43CA213649-01
|
$224,700
|
HOFFMAN, ROBERT
|
ANTICANCER, INC.
|
|
(PQ5) Exploring the Biological Distinctions between HIV-related and Endemic Pediatric Kaposi Sarcoma in a Kaposi Sarcoma-Associated Herpesvirus-Endemic Region of Africa
|
1R21CA217137-01
|
$209,093
|
EL-MALLAWANY, NADER
|
BAYLOR COLLEGE OF MEDICINE
|
|
ENHANCING T CELL THERAPY OF CANCER
|
5P01CA094237-15
|
$1,932,287
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Identifying and targeting oncogenic Myc enhancer control in pediatric tumors
|
1R01CA215452-01
|
$362,569
|
LIN, CHARLES
|
BAYLOR COLLEGE OF MEDICINE
|
|
Identifying and targeting oncogenic Myc enhancer control in pediatric tumors
|
3R01CA215452-01S1
|
$14,309
|
LIN, CHARLES
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S1
|
$118,333
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S2
|
$118,875
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S3
|
$122,250
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S4
|
$250,002
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-11
|
$3,253,119
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Dissecting the molecular and functional role of ILK in driving metastatic colonization and progression in Ewing sarcoma
|
1R03CA215940-01
|
$75,288
|
YUSTEIN, JASON
|
BAYLOR COLLEGE OF MEDICINE
|
|
Unmasking the roles of KSHV glycoproteins in virus entry and vaccine development
|
5K01CA184388-04
|
$108,798
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Investigation and functional characterization of new drivers of mesenchymal tumorigenesis.
|
5K99CA212200-02
|
$102,130
|
GUARNERIO, JLENIA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Functional characterization of the telomere repeat containing RNA, TERRA, in telomere maintenance
|
1R01CA214880-01
|
$376,294
|
FLYNN, RACHEL
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Molecular Mechanisms Regulating the Alternative Lengthening of Telomeres Pathway
|
5R01CA201446-02
|
$376,294
|
FLYNN, RACHEL
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Developing a translational pipeline for NF1-mutant malignancies
|
5U01CA202943-02
|
$380,076
|
CICHOWSKI, KAREN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic and Biochemical Studies of KSHV LANA
|
5R01CA082036-18
|
$421,563
|
KAYE, KENNETH
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
In vivo imaging of single circulating cells
|
5R01CA186567-06
|
$717,674
|
WANG, LIHONG
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
Determining the Epigenetic Mechanisms Driving Tissue Factor (F3) Upregulation and its Role in Metastatic Osteosarcoma
|
1F31CA213965-01A1
|
$44,044
|
BAYLES, IAN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S1
|
$118,875
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S2
|
$60,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S3
|
$200,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S4
|
$145,821
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-27
|
$4,895,515
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Repurposing Anti-cancer Drugs to Prevent Growth of Osteosarcoma Metastases
|
5R21CA209304-02
|
$206,843
|
GREENFIELD, EDWARD
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Targeting VCAM1-a4b1 Signaling to Ameliorate Pulmonary Osteosarcoma Metastasis
|
1R21CA218790-01
|
$208,637
|
HUANG, ALEX
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Defining novel drivers and predictive signatures of metastasis in osteosarcoma th
|
5F30CA186633-04
|
$49,044
|
MORROW, JAMES
|
CASE WESTERN RESERVE UNIVERSITY
|
|
IRF2BP2 modification by Cdk5 modulates interferon-gamma response tumor PD-L1 level
|
1R03CA219725-01
|
$80,000
|
PETROSIUTE, AGNE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Role of enhancer elements in regulating prometastatic transcriptional programs in osteosarcoma
|
5R01CA193677-02
|
$362,569
|
SCACHERI, PETER
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Connecting Genomic Alterations in Liposarcomas with Drug Responses and Identification of New Therapeutic Approaches
|
5R01CA200992-02
|
$363,125
|
KOEFFLER, HAROLD
|
CEDARS-SINAI MEDICAL CENTER
|
|
Cytokine- and Satellite Cell-mediated Muscle Disease Promotion
|
5R01CA189299-03
|
$337,941
|
KELLER, CHARLES
|
CHILDREN'S CANCER THERAPY DEVELOP/INST
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-04S1
|
$1,393,520
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Solid Malignancy Integrated Translational Science Center
|
5U10CA180884-04
|
$400,000
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-04
|
$22,547,116
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Bone and Soft Tissue Tumor Etiology: Role and Function of TRE17/USP6
|
5R01CA168452-05
|
$259,058
|
CHOU, MARGARET
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Bench to bedside: non-invasive treatment of tumors in children
|
1U01CA202947-01A1
|
$350,585
|
KIM, PETER
|
CHILDREN'S RESEARCH INSTITUTE
|
|
Optimizing Novel Immunotherapy Combinations Targeting the Tumor Microenvironment in Canine Spontaneous Osteosarcoma
|
1U01CA224182-01
|
$1,672,078
|
DOW, STEVEN
|
COLORADO STATE UNIVERSITY
|
|
Early Stage Diagnosis of Kaposi's Sarcoma in Limited Resource Settings using KS-Detect
|
5UH2CA202723-02
|
$498,956
|
ERICKSON, DAVID
|
CORNELL UNIVERSITY
|
|
SPORE: DF/HCC SPORE in GASTROINTESTINAL CANCER
|
5P50CA127003-10
|
$2,293,187
|
BASS, ADAM
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S2
|
$60,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S3
|
$100,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Targeting FAK and integrin signaling in preclinical models of Ewing sarcoma
|
5K08CA188073-03
|
$177,120
|
CROMPTON, BRIAN
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
2P30CA006516-52
|
$11,592,798
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S1
|
$112,500
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Misassembled BAF complexes in human cancer: structural and functional consequences
|
5F31CA196218-03
|
$29,705
|
POYNTER, STEVEN
|
DANA-FARBER CANCER INST
|
|
Dissecting the Pathogenesis of Ewing Sarcoma with Integrative Genomics
|
1R01CA204915-01A1
|
$396,547
|
STEGMAIER, KIMBERLY
|
DANA-FARBER CANCER INST
|
|
Dissecting the Pathogenesis of Ewing Sarcoma with Integrative Genomics
|
3R01CA204915-01A1S1
|
$228,600
|
STEGMAIER, KIMBERLY
|
DANA-FARBER CANCER INST
|
|
Integrating Transforming Approaches to Identify and Target New Vulnerabilities in Cancer
|
5R35CA210030-02
|
$1,046,441
|
STEGMAIER, KIMBERLY
|
DANA-FARBER CANCER INST
|
|
Dissecting the oncogenic mechanisms of SMARCB1 (BAF47) loss in malignant rhabdoid tumor
|
1F31CA217162-01
|
$37,030
|
VALENCIA, ALFREDO
|
DANA-FARBER CANCER INST
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|